Neogenin hFc Chimera, Human
Neogenin HFc Chimera, Human

Immobilized Human RGMa, His Tag at 5 μg/ml (100 μI/well) on the plate. Dose response curve for Neogenin hFc Chimera, Human, hFc Tag with the EC50 of 0.18 μg/ml determined by ELISA.

Neogenin HFc Chimera, Human

The purity of Neogenin hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

Neogenin HFc Chimera, Human

Neogenin hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Neogenin hFc Chimera, Human

Neogenin is a multifunctional transmembrane receptor belonging to the immunoglobulin superfamily. It displays identical secondary structure to deleted in colorectal cancer (DCC), a netrin receptor that is involved in axon guidance and cell survival.
Z05676
¥72,752.00

Ask us a question
Product Introduction
Species Human
Protein Construction
Neogenin (Ala34-Leu1105)_x000D_
Accession # Q92859-1		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 144.37 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 150-180 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • Neogenin HFc Chimera, Human
    • Neogenin HFc Chimera, Human

    Immobilized Human RGMa, His Tag at 5 μg/ml (100 μI/well) on the plate. Dose response curve for Neogenin hFc Chimera, Human, hFc Tag with the EC50 of 0.18 μg/ml determined by ELISA.

  • Neogenin HFc Chimera, Human
    • Neogenin HFc Chimera, Human

    The purity of Neogenin hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

  • Neogenin HFc Chimera, Human
    • Neogenin HFc Chimera, Human

    Neogenin hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Neogenin is a multifunctional transmembrane receptor belonging to the immunoglobulin superfamily. It displays identical secondary structure to deleted in colorectal cancer (DCC), a netrin receptor that is involved in axon guidance and cell survival.
Synonyms NEO1; IGDCC2; NGN; NEO; neogenin 1;

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.